NEW YORK, Sept 29 – Chipmaker Ciphergen Biosystems (Nasdaq: CIPH) showed a gain of 100 percent on its first day of trading while bioinformatics company Genomica (Nasdaq: GNOM) gained only 2 percent.

Winton Gibbons, genomics analyst at William Blair, said, “Ciphergen’s strength reflects proteomics as being one of the important major investment areas in the post-genomic era. The fact that Genomica is relatively flat reflects that it’s difficult for a bioinformatics company to attract attention without proprietary content, even though its software is good.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.